PECAM1 and neoplasm: Tissue-based studies did not exhibit appreciable differences in CD31 marker staining for angiogenesis following treatment, while H&E staining was performed at the endpoint and is shown in Figure 3B. H&E staining highlighted tumour regrowth in all treatment groups with some necrosis visible but no necrotic core (Figure 3B).